| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Ferrer Roca, Ricard |
| dc.contributor.author | Del Pozo, José Luis |
| dc.contributor.author | Garcia-Vidal, Carolina |
| dc.contributor.author | Garnacho-Montero, Jose |
| dc.contributor.author | Larrosa Escartin, María Nieves |
| dc.contributor.author | Canton, Rafael |
| dc.contributor.author | Soriano, Alex |
| dc.date.accessioned | 2022-11-23T09:16:15Z |
| dc.date.available | 2022-11-23T09:16:15Z |
| dc.date.issued | 2022-07-21 |
| dc.identifier.citation | Ferrer R, Soriano A, Cantón R, Del Pozo JL, García-Vidal C, Garnacho-Montero J, et al. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria. Rev Esp Quimioter. 2022 Jul 21;35(5):455–67. |
| dc.identifier.issn | 0214-3429 |
| dc.identifier.uri | https://hdl.handle.net/11351/8522 |
| dc.description | Resistència a múltiples fàrmacs; Factor de risc; Colonització |
| dc.description.sponsorship | This study was funded by Shionogi S.L.U. |
| dc.language.iso | eng |
| dc.publisher | Sociedad Española de Quimioterapia |
| dc.relation.ispartofseries | Revista Española de Quimioterapia;35(5) |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
| dc.source | Scientia |
| dc.subject | Presa de decisions |
| dc.subject | Malalties bacterianes gramnegatives - Tractament |
| dc.subject | Medicaments antibacterians - Ús terapèutic |
| dc.subject.mesh | Gram-Negative Bacterial Infections |
| dc.subject.mesh | /drug therapy |
| dc.subject.mesh | Anti-Bacterial Agents |
| dc.subject.mesh | /therapeutic use |
| dc.subject.mesh | Consensus |
| dc.title | A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.37201/req/062.2022 |
| dc.subject.decs | infecciones por bacterias gramnegativas |
| dc.subject.decs | /farmacoterapia |
| dc.subject.decs | antibacterianos |
| dc.subject.decs | /uso terapéutico |
| dc.subject.decs | consenso |
| dc.relation.publishversion | http://www.doi.org/10.37201/req/062.2022 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Ferrer R] Servicio de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Soriano A, García-Vidal C] Servicio de Enfermedades Infecciosas, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, Spain. [Cantón R] Servicio de Microbiología, Hospital Universitario Ramón y Cajal e Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. [Del Pozo JL] Servicio de Enfermedades Infecciosas y Microbiología Clínica, Universidad de Navarra, Spain. [Garnacho-Montero J] Unidad Clínica Cuidados Intensivos, Hospital Universitario Virgen de la Macarena, Seville, Spain. [Larrosa N] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 35859521 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |